IP Commercializer PureTech's CEO Outlines 2018 Roadmap After Financing
Daphne Zohar tells Scrip PureTech will use $100m placing to develop Boston-based group's growth-stage affiliates and advance its "BIG" proprietary pipeline of brain-immune-gut assets.
